Literature DB >> 25416515

Endometriotic mesenchymal stem cells exhibit a distinct immune phenotype.

Aghila Rani Koippallil Gopalakrishnan Nair1, Hrishikesh Pandit1, Neeta Warty2, Taruna Madan3.   

Abstract

Endometriosis is a significant debilitating gynecological problem affecting women of the reproductive age group and post-menopause. Recent reports suggest a role for endometriotic mesenchymal stem cells (ectopic MSCs) in the pathogenesis of endometriosis. To investigate the plausible mechanisms leading to the pathogenic behavior of ectopic MSCs, we compared the immunomodulatory properties of eutopic (healthy) and ectopic MSCs. We analyzed MSC phenotypes, differentiation potential, differential gene expression for an array of pattern recognition receptors (PRRs) and pro-inflammatory cytokine release along with markers of migration and angiogenesis among eutopic and ectopic MSCs. Further, alterations in immunosuppressive functions of eutopic and ectopic MSCs were examined by co-culturing them with mitogen-activated allogeneic PBMCs. Transcripts of PRRs such as all Toll-like receptors (TLR1-10), except TLR8, collectins (CL-L1, CL-P1 and CL-K1), NOD-1 and NOD-2 receptors and secreted pro-inflammatory cytokines like IL-6, IFN-γ, vascular endothelial growth factor (VEGF), epidermal growth factor and MCP-1 were significantly up-regulated in ectopic MSCs. The anti-inflammatory cytokine transforming growth factor-β showed significant down-regulation, while IL-10 showed a significant increase in ectopic MSCs. Further, ectopic MSCs showed up-regulated expression for markers of migration and angiogenesis such as matrix metalloproteinase-2 (MMP-2), MMP-3 and MMP-9 and VEGF, respectively. We report here that proliferation of PBMCs was less inhibited upon co-culture with ectopic MSCs compared with eutopic MSCs. The findings suggest that ectopic MSCs with increased levels of TLRs, collectins, pro-inflammatory cytokines and markers of migration and angiogenesis exhibit a distinct immune phenotype compared to eutopic MSCs. This distinct phenotype may be responsible for the reduced immunosuppressive property of ectopic MSCs and may be associated with the pathogenesis of endometriosis. © The Japanese Society for Immunology. 2014. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Toll-like receptors; endometriosis; immunomodulation; pattern recognition receptors; pro-inflammatory cytokines

Mesh:

Substances:

Year:  2014        PMID: 25416515     DOI: 10.1093/intimm/dxu103

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  9 in total

1.  Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice.

Authors:  A R Koippallil Gopalakrishnan; H Pandit; S M Metkari; N Warty; T Madan
Journal:  Gene Ther       Date:  2016-03-18       Impact factor: 5.250

Review 2.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 3.  Somatic stem cells and their dysfunction in endometriosis.

Authors:  Dusan Djokovic; Carlos Calhaz-Jorge
Journal:  Front Surg       Date:  2015-01-06

4.  Cell Expansion-Dependent Inflammatory and Metabolic Profile of Human Bone Marrow Mesenchymal Stem Cells.

Authors:  Patricia Prieto; María Fernández-Velasco; María E Fernández-Santos; Pedro L Sánchez; Verónica Terrón; Paloma Martín-Sanz; Francisco Fernández-Avilés; Lisardo Boscá
Journal:  Front Physiol       Date:  2016-11-16       Impact factor: 4.566

5.  Mesenchymal Stromal Cells Are More Immunosuppressive In Vitro If They Are Derived from Endometriotic Lesions than from Eutopic Endometrium.

Authors:  Fawaz Abomaray; Sebastian Gidlöf; Cecilia Götherström
Journal:  Stem Cells Int       Date:  2017-11-05       Impact factor: 5.443

6.  Genetic overlap between endometriosis and endometrial cancer: evidence from cross-disease genetic correlation and GWAS meta-analyses.

Authors:  Jodie N Painter; Tracy A O'Mara; Andrew P Morris; Timothy H T Cheng; Maggie Gorman; Lynn Martin; Shirley Hodson; Angela Jones; Nicholas G Martin; Scott Gordon; Anjali K Henders; John Attia; Mark McEvoy; Elizabeth G Holliday; Rodney J Scott; Penelope M Webb; Peter A Fasching; Matthias W Beckmann; Arif B Ekici; Alexander Hein; Matthias Rübner; Per Hall; Kamila Czene; Thilo Dörk; Matthias Dürst; Peter Hillemanns; Ingo Runnebaum; Diether Lambrechts; Frederic Amant; Daniela Annibali; Jeroen Depreeuw; Adriaan Vanderstichele; Ellen L Goode; Julie M Cunningham; Sean C Dowdy; Stacey J Winham; Jone Trovik; Erling Hoivik; Henrica M J Werner; Camilla Krakstad; Katie Ashton; Geoffrey Otton; Tony Proietto; Emma Tham; Miriam Mints; Shahana Ahmed; Catherine S Healey; Mitul Shah; Paul D P Pharoah; Alison M Dunning; Joe Dennis; Manjeet K Bolla; Kyriaki Michailidou; Qin Wang; Jonathan P Tyrer; John L Hopper; Julian Peto; Anthony J Swerdlow; Barbara Burwinkel; Hermann Brenner; Alfons Meindl; Hiltrud Brauch; Annika Lindblom; Jenny Chang-Claude; Fergus J Couch; Graham G Giles; Vessela N Kristensen; Angela Cox; Krina T Zondervan; Dale R Nyholt; Stuart MacGregor; Grant W Montgomery; Ian Tomlinson; Douglas F Easton; Deborah J Thompson; Amanda B Spurdle
Journal:  Cancer Med       Date:  2018-04-02       Impact factor: 4.452

Review 7.  Pathogenomics of Endometriosis Development.

Authors:  Vladislav Baranov; Olga Malysheva; Maria Yarmolinskaya
Journal:  Int J Mol Sci       Date:  2018-06-23       Impact factor: 5.923

8.  Biological characteristics of endometriotic mesenchymal stem cells isolated from ectopic lesions of patients with endometriosis.

Authors:  Yanli Liu; Shengying Liang; Fen Yang; Yuliang Sun; Lidan Niu; Yakun Ren; Hongmei Wang; Yanan He; Jiang Du; Jun Yang; Juntang Lin
Journal:  Stem Cell Res Ther       Date:  2020-08-08       Impact factor: 6.832

Review 9.  Association of Polymorphisms of MASP1/3, COLEC10, and COLEC11 Genes with 3MC Syndrome.

Authors:  Gabriela Gajek; Anna S Świerzko; Maciej Cedzyński
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.